Point Of Care Diagnostics Market Size, Share & Trends Report

Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-046-0
  • Number of Pages: 295
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Point Of Care Diagnostics Product Outlook (Revenue in USD Billion, 2018 - 2030)
    • Glucose Testing
    • Hb1Ac Testing
    • Coagulation Testing
    • Fertility/Pregnancy
    • Infectious Disease
      • HIV POC
      • Clostridium Difficile POC
      • HBV POC
      • Pneumonia or Streptococcus Associated Infections
      • Respiratory Syncytial Virus (RSV) POC
      • HPV POC
      • Influenza/Flu POC
      • HCV POC
      • MRSA POC
      • TB and Drug-resistant TB POC
      • HSV POC
      • COVID-19
      • Other Infectious Diseases
    • Cardiac Markers
    • Thyroid Stimulating Hormone
    • Hematology
    • Primary Care Systems
    • Decentralized Clinical Chemistry
    • Feces
    • Lipid Testing
    • Cancer Marker
    • Blood Gas/Electrolytes
    • Ambulatory Chemistry
    • Drug of Abuse (DOA) Testing
    • Autoimmune Diseases
    • Urinalysis/Nephrology
  • Point Of Care Diagnostics End Use Outlook (Revenue in USD Billion, 2018 - 2030)
    • Clinics
      • Pharmacy & Retail Clinics
      • Physician Office
      • Urgent Care Clinics
      • Non-practice Clinics
    • Hospitals
    • Home
    • Assisted Living Healthcare Facilities
    • Laboratory
  • Point Of Care Diagnostics Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • North America Product Outlook (Revenue in USD Billion, 2018 - 2030)
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
          • HIV POC
          • Clostridium Difficile POC
          • HBV POC
          • Pneumonia or Streptococcus Associated Infections
          • Respiratory Syncytial Virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and Drug-resistant TB POC
          • HSV POC
          • COVID-19
          • Other Infectious Diseases
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Autoimmune Diseases
        • Urinalysis/Nephrology
      • North America End Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Clinics
          • Pharmacy & Retail Clinics
          • Physician Office
          • Urgent Care Clinics
          • Non-practice Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratory
      • U.S.
        • U.S. Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • U.S. End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Canada
        • Canada Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Canada End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
    • Europe
      • Europe Product Outlook (Revenue in USD Billion, 2018 - 2030)
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
          • HIV POC
          • Clostridium Difficile POC
          • HBV POC
          • Pneumonia or Streptococcus Associated Infections
          • Respiratory Syncytial Virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and Drug-resistant TB POC
          • HSV POC
          • COVID-19
          • Other Infectious Diseases
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Autoimmune Diseases
        • Urinalysis/Nephrology
      • Europe End Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Clinics
          • Pharmacy & Retail Clinics
          • Physician Office
          • Urgent Care Clinics
          • Non-practice Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratory
      • Germany
        • Germany Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Germany End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • U.K.
        • U.K. Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • U.K. End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • France
        • France Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • France End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Italy
        • Italy Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Italy  End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Spain
        • Spain Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Spain End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Russia
        • Russia Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Russia End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Denmark
        • Denmark Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Denmark End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Sweden
        • Sweden Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Sweden End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Norway
        • Norway  Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Norway End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
    • Asia Pacific
      • Asia Pacific Product Outlook (Revenue in USD Billion, 2018 - 2030)
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
          • HIV POC
          • Clostridium Difficile POC
          • HBV POC
          • Pneumonia or Streptococcus Associated Infections
          • Respiratory Syncytial Virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and Drug-resistant TB POC
          • HSV POC
          • COVID-19
          • Other Infectious Diseases
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Autoimmune Diseases
        • Urinalysis/Nephrology
      • Asia Pacific End Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Clinics
          • Pharmacy & Retail Clinics
          • Physician Office
          • Urgent Care Clinics
          • Non-practice Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratory
      • Japan
        • Japan Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Japan End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • China
        • China Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • China End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • India
        • India Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • India End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • South Korea
        • South Korea Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • South Korea End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Australia
        • Australia Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Australia  End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Thailand
        • Thailand Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Thailand End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
    • Latin America
      • Latin America Product Outlook (Revenue in USD Billion, 2018 - 2030)
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
          • HIV POC
          • Clostridium Difficile POC
          • HBV POC
          • Pneumonia or Streptococcus Associated Infections
          • Respiratory Syncytial Virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and Drug-resistant TB POC
          • HSV POC
          • COVID-19
          • Other Infectious Diseases
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Autoimmune Diseases
        • Urinalysis/Nephrology
      • Latin America End Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Clinics
          • Pharmacy & Retail Clinics
          • Physician Office
          • Urgent Care Clinics
          • Non-practice Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratory
      • Brazil
        • Brazil Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Brazil End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Mexico
        • Mexico Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Mexico End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Argentina
        • Argentina Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Argentina End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
    • Middle East and Africa (MEA)
      • MEA Product Outlook (Revenue in USD Billion, 2018 - 2030)
        • Glucose Testing
        • Hb1Ac Testing
        • Coagulation Testing
        • Fertility/Pregnancy
        • Infectious Disease
          • HIV POC
          • Clostridium Difficile POC
          • HBV POC
          • Pneumonia or Streptococcus Associated Infections
          • Respiratory Syncytial Virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and Drug-resistant TB POC
          • HSV POC
          • COVID-19
          • Other Infectious Diseases
        • Cardiac Markers
        • Thyroid Stimulating Hormone
        • Hematology
        • Primary Care Systems
        • Decentralized Clinical Chemistry
        • Feces
        • Lipid Testing
        • Cancer Marker
        • Blood Gas/Electrolytes
        • Ambulatory Chemistry
        • Drug of Abuse (DOA) Testing
        • Autoimmune Diseases
        • Urinalysis/Nephrology
      • MEA End Use Outlook (Revenue in USD Billion, 2018 - 2030)
        • Clinics
          • Pharmacy & Retail Clinics
          • Physician Office
          • Urgent Care Clinics
          • Non-practice Clinics
        • Hospitals
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratory
      • South Africa
        • South Africa Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • South Africa End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Saudi Arabia
        • Saudi Arabia Product Outlook (Revenue in USD Billion, 2018 - 2030)
        • Saudi Arabia End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • UAE
        • UAE Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • UAE End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory
      • Kuwait
        • Kuwait Product Outlook (Revenue in USD Billion, 2018 - 2030)
          • Glucose Testing
          • Hb1Ac Testing
          • Coagulation Testing
          • Fertility/Pregnancy
          • Infectious Disease
            • HIV POC
            • Clostridium Difficile POC
            • HBV POC
            • Pneumonia or Streptococcus Associated Infections
            • Respiratory Syncytial Virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and Drug-resistant TB POC
            • HSV POC
            • COVID-19
            • Other Infectious Diseases
          • Cardiac Markers
          • Thyroid Stimulating Hormone
          • Hematology
          • Primary Care Systems
          • Decentralized Clinical Chemistry
          • Feces
          • Lipid Testing
          • Cancer Marker
          • Blood Gas/Electrolytes
          • Ambulatory Chemistry
          • Drug of Abuse (DOA) Testing
          • Autoimmune Diseases
          • Urinalysis/Nephrology
        • Kuwait End Use Outlook (Revenue in USD Billion, 2018 - 2030)
          • Clinics
            • Pharmacy & Retail Clinics
            • Physician Office
            • Urgent Care Clinics
            • Non-practice Clinics
          • Hospitals
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratory

Point Of Care Diagnostics Market Dynamics

Driver: Growing Geriatric Population Base

The increasing geriatric population is also contributing to the expansion of the point-of-care diagnostics market, as the elderly population is more susceptible to chronic diseases, including diabetes, cardiovascular disorders, & respiratory illnesses. Point-of-care diagnostics play a vital role in managing these conditions by enabling convenient and regular monitoring of biomarkers, such as blood glucose levels, cholesterol, & lung function. As the global geriatric population continues to grow, the demand for point-of-care diagnostic devices and tests is expected to rise, driving market growth.

The growing geriatric population seeking companionship, security, and help with daily activities is a major element driving segment growth. Increased life expectancy is expected to result in rapid growth of the geriatric population in the coming years. According to the National Institute on Aging (NIA), about 8.5% of the world's population is aged 65 and above. According to the Population Reference Bureau, people aged 65 and above in the U.S. are expected to increase from 55.8 million in 2020 to 95 million by 2060. In addition, the global market for ALFs is likely to be driven by technological advancements. The market is expected to benefit from the development of advanced and easy-to-use equipment and services, including Internet-enabled home monitoring, telemedicine, and mobile health apps over the projected period

Driver: Growing Prevalence of Target Diseases

The high prevalence of cardiac diseases and the need for effective & rapid diagnostic procedures (POC) in an attempt to timely curb the incidence rates are expected to support the projected growth. According to statistics published by the International Diabetes Federation, the global prevalence of diabetes will increase from 537 million in 2021 to 643 million by 2030 and is expected to reach 783 million by 2045. Moreover, increasing demand for home healthcare due to the rising prevalence of diabetes is anticipated to drive market growth. Owing to the growing demand for home healthcare-based POC diagnostic procedures in the rural and remote areas of countries such as India & China, the need for OTC and rapid diagnostic kits is expected to increase over the next 7 years, causing a rise in revenue generation.

Regular glucose testing is of utmost importance for diabetic patients. As per Diabetes Control and Complications Trial, the use of blood glucose monitors helps in lowering disease complications. POC glucose monitors are used for periodic monitoring of blood glucose, which helps doctors decide on appropriate treatment patterns. Over-the-counter (OTC) or rapid tests and prescription tests are the POC tests that are useful for the determination of blood glucose levels in hospitals and other POC settings. The rising prevalence of diabetes and the introduction of technologically advanced and portable diagnostic solutions are expected to boost market growth during the forecast period. For instance, in January 2022, Roche announced the launch of a hand-held, smart glucose meter to be used in hospital settings. Blood glucose POC diagnostics have gained immense demand, which can be attributed to convenient handling and associated affordability. This enables the near-to-immediate assessment of patients who are critically ill, wherein immediate test results are imperative to design further treatment approaches. Thus, glucose POC diagnostic solutions are also becoming a valuable resource in the U.S., with more than 20 million residents affected by diabetes, propelling the concept of self-testing and on-site testing.

Restraint: Presence of Ambiguous Regulatory and Reimbursement Framework for Primary Care Setting

Healthcare professionals operating across hospital settings face several issues, such as complex regulatory demand for accreditation of POC, satisfaction levels of the personnel, lack of coordination between clinical groups, and its impact on the alternative tests introduced in the market. The U.S. FDA and the Center for Devices and Radiological Health are the regulatory agencies that approve POC tests through the 510(K) process. ISO 15189 indicates requirements for competence and quality in medical laboratories. It can be used by medical laboratories to develop their quality management systems to assess their own expertise in POCT. It can also be used for recognizing or confirming the competency of medical laboratories by regulating authorities, accreditation bodies, and laboratory customers. Federal regulation of POCT is minimal, and accrediting agencies and states regularly enforce additional requirements. It focuses on two areas:

  • Competency and training of the person conducting the testing

  • Authentication of stringent adherence to the manufacturer-specified method for every test.

Most plans rely on the CMS fee schedule as a reference point; the internal review may also be conducted by a health plan. Payers would not reimburse providers for the cost of any additional instrumentation and equipment of the test reader. These costs have to be recovered in the fee schedule for claims to perform the test. The reimbursement policies are complex and regionally discrepant. For instance, in China, there is no established protocol for being included in the list or qualifying for reimbursement. In China, the National Drug Reimbursement List (NDRL) must align with the expenses that can be covered by the Basic Medical Insurance (BMI) funds on an annual basis.

What Does This Report Include?

This section will provide insights into the contents included in this point of care diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Point of care diagnostics market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Point of care diagnostics market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon